Literature DB >> 12693954

Molecular dissection of the architectural transcription factor HMGA2.

Barbara Noro1, Barbara Licheri, Riccardo Sgarra, Alessandra Rustighi, Michela A Tessari, Kai-Yin Chau, Santa Jeremy Ono, Vincenzo Giancotti, Guidalberto Manfioletti.   

Abstract

HMGA2 protein belongs to the High Mobility Group A (HMGA) family of architectural transcription factors. These proteins establish a network of protein-protein and protein-DNA interactions resulting in the formation of enhanceosomes at promoters and enhancers regulating the expression of several genes. HMGA2 dysregulation, as a result of specific chromosomal rearrangements, has been identified in a variety of common benign mesenchymal tumors, and transgenic mice expressing a truncated form of HMGA2 protein demonstrated a causal relationship between the expression of the HMGA2 protein and tumorigenesis. In this paper, using several recombinant mutant proteins, we have investigated the role played by the different domains of HMGA2 in protein-protein and protein-DNA interaction. Using the IFN-beta gene as a model, we have shown that a short region of HMGA2, comprising the second DNA-binding domain, is critical for enhancing the NF-kappaB complex formation, for binding to the PRDII element, and also for protein-protein interaction with the NF-kappaB p50 subunit. Moreover, we have analyzed the interaction of HMGA2 mutant proteins with different DNA targets demonstrating that the absence of the C-terminal tail alters HMGA2/DNA complexes in a subset of DNA sequences. Our results suggest possible implications for the role of HMGA2 in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12693954     DOI: 10.1021/bi026605k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Inhibition of high-mobility-group A2 protein binding to DNA by netropsin: a biosensor-surface plasmon resonance assay.

Authors:  Yi Miao; Tengjiao Cui; Fenfei Leng; W David Wilson
Journal:  Anal Biochem       Date:  2007-10-23       Impact factor: 3.365

2.  FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.

Authors:  Wei Wei; Samuel C Mok; Esther Oliva; Sung-hoon Kim; Gayatry Mohapatra; Michael J Birrer
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

3.  Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition.

Authors:  E-Jean Tan; Sylvie Thuault; Laia Caja; Tea Carletti; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

4.  Hmga2 regulates self-renewal of retinal progenitors.

Authors:  Sowmya Parameswaran; Xiaohuan Xia; Ganapati Hegde; Iqbal Ahmad
Journal:  Development       Date:  2014-11       Impact factor: 6.868

5.  Core promoter-selective function of HMGA1 and Mediator in Initiator-dependent transcription.

Authors:  Muyu Xu; Priyanka Sharma; Songqin Pan; Sohail Malik; Robert G Roeder; Ernest Martinez
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

6.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

7.  Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.

Authors:  Kai-Yin Chau; Guidalberto Manfioletti; Kam-Wa Cheung-Chau; Alfredo Fusco; Nathalie Dhomen; Jane C Sowden; Tetsuo Sasabe; Shizuo Mukai; Santa Jeremy Ono
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

8.  Association of a high mobility group gene (HMGA2) variant with bone mineral density.

Authors:  Allison Kuipers; Yingze Zhang; Jane A Cauley; Cara S Nestlerode; Yanxia Chu; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Andrew R Hoffman; Eric S Orwoll; Joseph M Zmuda
Journal:  Bone       Date:  2009-04-17       Impact factor: 4.398

9.  SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

Authors:  Xuefei Cao; Carlos Clavijo; Xu Li; H Helen Lin; Yuan Chen; Hsiu-Ming Shih; David K Ann
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

10.  HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.

Authors:  Sylvie Thuault; E-Jean Tan; Hector Peinado; Amparo Cano; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.